Engelson Erik T. - 15 Mar 2022 Form 4 Insider Report for Lucira Health, Inc.

Role
President and Chief Executive, Director
Signature
/s/ Dan George, Attorney-in-Fact for Erik T. Engelson
Issuer symbol
N/A
Transactions as of
15 Mar 2022
Net transactions value
+$90,000
Form type
4
Filing time
16 Mar 2022, 18:47:41 UTC
Next filing
17 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LHDXQ Common Stock Purchase $90,000 +30,000 +129% $3.00* 53,282 15 Mar 2022 Direct
holding LHDXQ Common Stock 46,400 15 Mar 2022 See footnote F1
holding LHDXQ Common Stock 191,705 15 Mar 2022 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held by the Elisabeth North Kuechler Engelson Trust, dated January 17, 2001, for which Mr. Engelson serves as trustee.
F2 The shares are held by Epic Pacific, LLC, of which Mr. Engelson is a Member. Mr. Engelson disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.